Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$11.51 - $21.53 $51,795 - $96,885
-4,500 Reduced 22.5%
15,500 $181,000
Q1 2024

May 15, 2024

SELL
$12.17 - $24.61 $304,250 - $615,250
-25,000 Reduced 55.56%
20,000 $421,000
Q4 2023

Feb 14, 2024

BUY
$12.89 - $20.82 $580,050 - $936,900
45,000 New
45,000 $807,000
Q4 2022

Feb 14, 2023

SELL
$20.4 - $24.73 $61,199 - $74,190
-3,000 Reduced 10.0%
27,000 $612,000
Q2 2022

Aug 15, 2022

BUY
$19.35 - $35.04 $580,500 - $1.05 Million
30,000 New
30,000 $741,000
Q1 2022

May 13, 2022

SELL
$24.62 - $34.31 $738,600 - $1.03 Million
-30,000 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$30.19 - $40.28 $1.89 Million - $2.53 Million
-62,700 Reduced 67.64%
30,000 $981,000
Q3 2021

Nov 12, 2021

BUY
$29.09 - $45.68 $1.82 Million - $2.86 Million
62,700 Added 209.0%
92,700 $3.89 Million
Q2 2021

Aug 16, 2021

BUY
$32.46 - $40.48 $486,900 - $607,200
15,000 Added 100.0%
30,000 $1.17 Million
Q1 2021

May 17, 2021

SELL
$33.61 - $49.95 $504,150 - $749,250
-15,000 Reduced 50.0%
15,000 $512,000
Q4 2020

Feb 16, 2021

SELL
$26.52 - $49.35 $397,800 - $740,250
-15,000 Reduced 33.33%
30,000 $1.36 Million
Q3 2020

Nov 16, 2020

BUY
$27.01 - $40.26 $1.22 Million - $1.81 Million
45,000 New
45,000 $1.24 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $439M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.